362 related articles for article (PubMed ID: 21308882)
1. Treatment-emergent suicidal ideation during 4 months of acute management of unipolar major depression with SSRI pharmacotherapy or interpersonal psychotherapy in a randomized clinical trial.
Rucci P; Frank E; Scocco P; Calugi S; Miniati M; Fagiolini A; Cassano GB
Depress Anxiety; 2011 Apr; 28(4):303-9. PubMed ID: 21308882
[TBL] [Abstract][Full Text] [Related]
2. Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.
Perlis RH; Purcell S; Fava M; Fagerness J; Rush AJ; Trivedi MH; Smoller JW
Arch Gen Psychiatry; 2007 Jun; 64(6):689-97. PubMed ID: 17548750
[TBL] [Abstract][Full Text] [Related]
3. SSRI versus bupropion effects on symptom clusters in suicidal depression: post hoc analysis of a randomized clinical trial.
Grunebaum MF; Keilp JG; Ellis SP; Sudol K; Bauer N; Burke AK; Oquendo MA; Mann JJ
J Clin Psychiatry; 2013 Sep; 74(9):872-9. PubMed ID: 24107760
[TBL] [Abstract][Full Text] [Related]
4. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
[TBL] [Abstract][Full Text] [Related]
5. Time Course and Predictors of Suicidal Ideation During Citalopram Treatment in the STAR*D Trial.
Coughlin CG; Jakubovski E; Bloch MH
J Clin Psychiatry; 2016 Oct; 77(10):e1262-e1269. PubMed ID: 27631142
[TBL] [Abstract][Full Text] [Related]
6. The Association of Baseline Suicidality With Treatment Outcome in Psychotic Depression.
Bingham KS; Rothschild AJ; Mulsant BH; Whyte EM; Meyers BS; Banerjee S; Szanto K; Flint AJ;
J Clin Psychiatry; 2017; 78(8):1149-1154. PubMed ID: 28445632
[TBL] [Abstract][Full Text] [Related]
7. Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study.
Zisook S; Trivedi MH; Warden D; Lebowitz B; Thase ME; Stewart JW; Moutier C; Fava M; Wisniewski SR; Luther J; Rush AJ
J Affect Disord; 2009 Sep; 117(1-2):63-73. PubMed ID: 19217668
[TBL] [Abstract][Full Text] [Related]
8. Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy.
Frank E; Cassano GB; Rucci P; Thompson WK; Kraemer HC; Fagiolini A; Maggi L; Kupfer DJ; Shear MK; Houck PR; Calugi S; Grochocinski VJ; Scocco P; Buttenfield J; Forgione RN
Psychol Med; 2011 Jan; 41(1):151-62. PubMed ID: 20380782
[TBL] [Abstract][Full Text] [Related]
9. Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial.
Perroud N; Uher R; Marusic A; Rietschel M; Mors O; Henigsberg N; Hauser J; Maier W; Souery D; Placentino A; Szczepankiewicz A; Jorgensen L; Strohmaier J; Zobel A; Giovannini C; Elkin A; Gunasinghe C; Gray J; Campbell D; Gupta B; Farmer AE; McGuffin P; Aitchison KJ
BMC Med; 2009 Oct; 7():60. PubMed ID: 19832967
[TBL] [Abstract][Full Text] [Related]
10. Pilot randomized clinical trial of an SSRI vs bupropion: effects on suicidal behavior, ideation, and mood in major depression.
Grunebaum MF; Ellis SP; Duan N; Burke AK; Oquendo MA; John Mann J
Neuropsychopharmacology; 2012 Feb; 37(3):697-706. PubMed ID: 21993207
[TBL] [Abstract][Full Text] [Related]
11. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.
Lespérance F; Frasure-Smith N; Koszycki D; Laliberté MA; van Zyl LT; Baker B; Swenson JR; Ghatavi K; Abramson BL; Dorian P; Guertin MC;
JAMA; 2007 Jan; 297(4):367-79. PubMed ID: 17244833
[TBL] [Abstract][Full Text] [Related]
12. Genetic markers of suicidal ideation emerging during citalopram treatment of major depression.
Laje G; Paddock S; Manji H; Rush AJ; Wilson AF; Charney D; McMahon FJ
Am J Psychiatry; 2007 Oct; 164(10):1530-8. PubMed ID: 17898344
[TBL] [Abstract][Full Text] [Related]
13. Effects of vilazodone on suicidal ideation and behavior in adults with major depressive disorder or generalized anxiety disorder: post-hoc analysis of randomized, double-blind, placebo-controlled trials.
Thase ME; Edwards J; Durgam S; Chen C; Chang CT; Mathews M; Gommoll CP
Int Clin Psychopharmacol; 2017 Sep; 32(5):281-288. PubMed ID: 28538024
[TBL] [Abstract][Full Text] [Related]
14. Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.
Brent DA; Emslie GJ; Clarke GN; Asarnow J; Spirito A; Ritz L; Vitiello B; Iyengar S; Birmaher B; Ryan ND; Zelazny J; Onorato M; Kennard B; Mayes TL; Debar LL; McCracken JT; Strober M; Suddath R; Leonard H; Porta G; Keller MB
Am J Psychiatry; 2009 Apr; 166(4):418-26. PubMed ID: 19223438
[TBL] [Abstract][Full Text] [Related]
15. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
Hjalmarsson L; Corcos M; Jeammet P
Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
[TBL] [Abstract][Full Text] [Related]
16. Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial?
Perlis RH; Uher R; Perroud N; Fava M
J Clin Psychiatry; 2012 Nov; 73(11):1439-42. PubMed ID: 23059018
[TBL] [Abstract][Full Text] [Related]
17. The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.
KoKoAung E; Cavenett S; McArthur A; Aromataris E
JBI Database System Rev Implement Rep; 2015 Apr; 13(3):174-205. PubMed ID: 26447056
[TBL] [Abstract][Full Text] [Related]
18. Augmentation with citalopram for suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms: a randomized controlled trial.
Zisook S; Kasckow JW; Lanouette NM; Golshan S; Fellows I; Vahia I; Mohamed S; Rao S
J Clin Psychiatry; 2010 Jul; 71(7):915-22. PubMed ID: 20361918
[TBL] [Abstract][Full Text] [Related]
19. Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report.
McGrath PJ; Khan AY; Trivedi MH; Stewart JW; Morris DW; Wisniewski SR; Miyahara S; Nierenberg AA; Fava M; Rush AJ
J Clin Psychiatry; 2008 Dec; 69(12):1847-55. PubMed ID: 19026268
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
Trivedi MH; Rush AJ; Wisniewski SR; Nierenberg AA; Warden D; Ritz L; Norquist G; Howland RH; Lebowitz B; McGrath PJ; Shores-Wilson K; Biggs MM; Balasubramani GK; Fava M;
Am J Psychiatry; 2006 Jan; 163(1):28-40. PubMed ID: 16390886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
